FBBp was created to help convert the substantial ongoing public investment in the Fitzsimons Life Science District into a sustainable life sciences cluster. Faculty, entrepreneurs and companies are able to advance their innovations by leveraging our industry-specific expertise and resources.
The Fitzsimons Vision
Public funding of over $5 billion is transforming the former site of the Fitzsimons army base – all 578 acres – into a leading global science and technology campus. The project is anchored by the significant research and clinical capabilities and infrastructure of the following:+ Anschutz Medical Campus
+ University of Colorado Denver (UCD) including the Medical, Pharmacy, Dental and Nursing Schools
+ University of Colorado Cancer Center
+ University of Colorado Hospital
+ Barbara Davis Center for Childhood Diabetes
+ Children’s Hospital of Denver
+ Denver VA Hospital (opening 2012)
+ 184-acre Colorado Science + Technology Park at Fitzsimons
Together, the area is evolving into a self-contained bioscience ecosystem, capable of supporting the needs of a broad diversity of synergistic academic, clinical and commercial bioscience enterprises.
Core Infrastructure
It is capital-intensive, and usually imprudent, for small, growing companies to build out the substantial infrastructure necessary to attack the full gamut of discovery-to-clinic infrastructure. The University of Colorado has a variety of core facilities to support research, from biomolecular characterization to first-in-human studies, including:
+ Biomolecular Core: Peptide synth, X-ray crystallography, NMR
+ Biostatistics and Bioinformatics Core
+ Computational Biology Core
+ CytoGenics Core
+ DNA Sequencing and Analysis Core
+ Flow Cytometry Core
+ Laboratory Animal Core: GLP, rodent studies
+ Microarray Core: Affymetrix human/mouse, array fabrication
+ Metabolic Core
+ Pathology Core PCR
+ PCR Core: qRTPCR
+ Pharmacology Core
+ Protein Expression, Monoclonal Antibody, Tissue Culture Core
+ Proteomics Core